Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA minor revision entry (v3.3.2) was added and v3.2.0 was removed from the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page no longer shows the government funding/operating status notice. The banner warning about updates and operating status may no longer appear on the record history page.SummaryDifference0.8%

- Check42 days agoChange DetectedTwo updates to the recruitment status are recorded on the study record: 2023-02-13 and 2024-08-06.SummaryDifference0.1%

- Check71 days agoChange DetectedUpdated core content to reflect a new version (v3.2.0) and a government funding-related operating-status notice; the previous version tag (v3.1.0) was removed.SummaryDifference13%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check93 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; no other core content changes are evident. The removal of 'Back to Top' is a minor UI change.SummaryDifference0.8%

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.